# ANAB (Anaptysbio, Inc.) - SEC EDGAR Financial Statements

> Anaptysbio, Inc. reported $234.6M in revenue and a net loss of $13.23M for the fiscal year ended December 31, 2025 (up 157.0% year over year), with a 20.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/ANAB
- Markdown: https://convexityos.com/fundamentals/ANAB.md
- SEC CIK: 0001370053
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:26 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001370053&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $234.6M | +157.0% YoY |
| Operating Income | FY 2025 | $47.90M | 20.4% margin |
| Net Income | FY 2025 | -$13.23M | -5.6% net margin |
| Diluted EPS | FY 2025 | -$0.46 | Split-adjusted |
| Free Cash Flow | FY 2025 | $19.61M | 8.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $153.0M | Total debt: $12.57M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $234.6M | $91.28M | $17.16M | $10.29M | $63.17M | $75.00M | $8.00M | $5.00M | $10.00M | $16.68M |
| Research & Development | $136.0M | $163.8M | $132.3M | $88.80M | $98.50M | $80.03M | $99.34M | $56.20M | $29.44M | $15.42M |
| Total Operating Expenses | $186.7M | $206.2M | $181.6M | $125.4M | $120.0M | $98.88M | $115.4M | $71.72M | $38.78M | $19.71M |
| **Operating Income** | $47.90M | -$114.9M | -$164.4M | -$115.2M | -$56.81M | -$23.88M | -$107.4M | -$66.72M | -$28.78M | -$3.02M |
| **EBITDA** | $48.45M | -$114.3M | -$163.8M | -$114.5M | -$56.20M | -$23.32M | -$106.9M | -$66.41M | -$28.60M | -$2.79M |
| Interest Income | $13.50M | $19.79M | $18.87M | $7.55M | $431K | $3.96M | $10.98M | $6.68M | $1.62M | $127K |
| Interest Expense | -- | -- | -- | -- | $0 | $0 | $1.04M | $1.65M | $1.77M | $458K |
| Income Before Tax | -$13.07M | -$145.2M | -$163.6M | -$128.7M | -$57.80M | -$19.93M | -$97.49M | -$61.85M | -$30.07M | -$4.26M |
| Income Tax Expense | $164K | $3.0K | -$4.0K | $24K | $0 | $0 | -$152K | -$192K | $0 | $0 |
| **Net Income** | -$13.23M | -$145.2M | -$163.6M | -$128.7M | -$57.80M | -$19.93M | -$97.34M | -$61.66M | -$30.07M | -$4.26M |
| Basic EPS | -$0.46 | -$5.12 | -$6.08 | -$4.57 | -$2.11 | -$0.73 | -$3.60 | -$2.50 | -$1.52 | -$1.62 |
| **Diluted EPS** | -$0.46 | -$5.12 | -$6.08 | -$4.57 | -$2.11 | -$0.73 | -$3.60 | -$2.50 | -$1.52 | -$1.62 |
| Basic Shares Outstanding | 28.8M | 28.4M | 26.9M | 28.2M | 27.4M | 27.3M | 27.1M | 24.7M | 19.8M | 2.6M |
| Diluted Shares Outstanding | 28.8M | 28.4M | 26.9M | 28.2M | 27.4M | 27.3M | 27.1M | 24.7M | 19.8M | 2.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $30.27M | $25.56M | $108.2M | $76.32M | $22.26M | $27.77M | $43.11M | $30.02M |
| Research & Development | -- | $33.99M | -- | $31.41M | $37.82M | $41.18M | -- | $42.21M |
| Total Operating Expenses | $10.37M | $60.19M | $41.35M | -$952K | $48.43M | $55.31M | $52.78M | $52.77M |
| **Operating Income** | $19.91M | -$34.64M | $66.90M | $77.27M | -$26.17M | -$27.54M | -$9.67M | -$22.76M |
| **EBITDA** | $19.91M | -$34.51M | $67.03M | $77.28M | -$26.03M | -$27.39M | -$9.53M | -$22.61M |
| Interest Income | $1.44M | $2.65M | $2.51M | $1.86M | $3.65M | $4.41M | $5.26M | $5.32M |
| Income Before Tax | $3.27M | -$52.84M | $49.70M | $56.62M | -$38.59M | -$39.28M | -$21.79M | -$32.85M |
| Income Tax Expense | -$608K | $40K | $81K | $269K | $39K | $44K | -$6.0K | $0 |
| **Net Income** | $3.88M | -$52.88M | $49.61M | $15.11M | -$38.63M | -$39.33M | -$21.78M | -$32.85M |
| Basic EPS | $0.13 | -$1.84 | -- | $0.54 | -$1.34 | -$1.28 | -- | -$1.14 |
| **Diluted EPS** | $0.11 | -$1.84 | -- | $0.52 | -$1.34 | -$1.28 | -- | -$1.14 |
| Basic Shares Outstanding | 29.8M | 28.7M | -- | 27.8M | 28.8M | 30.6M | -- | 28.9M |
| Diluted Shares Outstanding | 35.1M | 28.7M | -- | 29.0M | 28.8M | 30.6M | -- | 28.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $238.2M | $123.1M | $35.97M | $71.31M | $495.7M | $250.5M | $171.0M | $113.6M | $81.19M | $51.23M |
| Short-Term Investments | $73.44M | $262.3M | $354.9M | $369.9M | $52.37M | $143.2M | $203.2M | $313.5M | $167.2M | $0 |
| **Cash & Short-Term Investments** | $311.6M | $385.4M | $390.9M | $441.2M | $548.1M | $393.7M | $374.2M | $427.1M | $248.4M | $51.23M |
| Accounts Receivable, Net | $33.85M | $40.77M | $6.85M | $1.42M | $876K | $0 | $0 | $0 | $0 | $1.23M |
| **Total Current Assets** | $350.2M | $431.9M | $406.8M | $447.2M | $553.9M | $396.6M | $377.7M | $434.2M | $252.7M | $58.21M |
| Property, Plant & Equipment, Net | $1.37M | $1.85M | $2.10M | $2.09M | $2.28M | $1.78M | $1.62M | $1.45M | $665K | $471K |
| Long-Term Investments | $0 | $35.47M | $27.03M | $142.9M | $67.10M | $17.55M | $54.30M | $73.13M | $75.90M | $0 |
| Other Non-Current Assets | $256K | $256K | $256K | $256K | $256K | $258K | $1.48M | $148K | $46K | -- |
| **Total Non-Current Assets** | $14.14M | $51.96M | $45.55M | $163.2M | $89.19M | $19.99M | $57.46M | $74.78M | $76.67M | $3.97M |
| **Total Assets** | $364.4M | $483.8M | $452.4M | $610.4M | $643.1M | $416.6M | $435.2M | $509.0M | $329.4M | $62.18M |
| Accounts Payable | $3.87M | $4.00M | $4.70M | $2.78M | $1.74M | $4.22M | $16.24M | $5.44M | $2.32M | $2.28M |
| Other Current Liabilities | -- | -- | -- | -- | -- | $342K | $871K | $58K | $17K | $1.0K |
| **Total Current Liabilities** | $38.62M | $45.43M | $37.44M | $26.05M | $16.10M | $19.82M | $29.54M | $21.84M | $14.09M | $5.71M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $0 | $654K | $796K | -- | -- |
| **Total Non-Current Liabilities** | $288.6M | $367.5M | $326.8M | $322.2M | $270.5M | $0 | $654K | $796K | $7.69M | $94.72M |
| **Total Liabilities** | $327.2M | $413.0M | $364.3M | $348.3M | $286.6M | $19.82M | $30.19M | $22.63M | $21.78M | $100.4M |
| **Total Debt (incl. Leases)** | $14K | $16.04M | $17.81M | $19.45M | $20.95M | $342K | $1.52M | -- | -- | -- |
| Common Stock | $28K | $30K | $27K | $29K | $28K | $27K | $27K | $27K | $24K | $3.0K |
| Retained Earnings | -$772.6M | -$759.3M | -$614.1M | -$450.5M | -$321.8M | -$264.0M | -$244.0M | -$146.7M | -$85.03M | -$54.92M |
| Accumulated Other Comp. Income | -$24K | $305K | -$797K | -$5.25M | -$422K | -$4.0K | $338K | -$223K | -$426K | $0 |
| **Total Stockholders' Equity** | $37.21M | $70.87M | $88.10M | $262.1M | $356.4M | $396.7M | $405.0M | $486.4M | $307.6M | -$38.25M |
| Total Equity | $37.21M | $70.87M | $88.10M | $262.1M | $356.4M | $396.7M | $405.0M | $486.4M | $307.6M | -$38.25M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $135.4M | $133.8M | $248.5M | $238.2M | $109.8M | $44.30M | $98.64M | $123.1M |
| Short-Term Investments | $17.60M | $30.32M | $37.99M | $73.44M | $139.1M | $221.4M | $241.3M | $262.3M |
| **Cash & Short-Term Investments** | $153.0M | $164.1M | $286.5M | $311.6M | $249.0M | $265.7M | $339.9M | $385.4M |
| Accounts Receivable, Net | $30.49M | $25.63M | $25.75M | $33.85M | $75.69M | $21.42M | $17.88M | $40.77M |
| **Total Current Assets** | $188.4M | $198.4M | $316.1M | $350.2M | $330.6M | $291.9M | $363.1M | $431.9M |
| Property, Plant & Equipment, Net | $97K | $102K | $1.28M | $1.37M | $1.50M | $1.63M | $1.74M | $1.85M |
| Long-Term Investments | -- | -- | -- | $0 | $7.70M | $28.00M | $43.02M | $35.47M |
| Other Non-Current Assets | $256K | $256K | $256K | $256K | $256K | $256K | $256K | $256K |
| **Total Non-Current Assets** | $118.7M | $118.6M | $13.57M | $14.14M | $22.45M | $43.34M | $58.94M | $51.96M |
| **Total Assets** | $307.0M | $317.0M | $329.7M | $364.4M | $353.1M | $335.2M | $422.1M | $483.8M |
| Accounts Payable | $879K | $4.39M | $7.52M | $3.87M | $2.89M | $3.33M | $6.12M | $4.00M |
| **Total Current Liabilities** | $22.42M | $35.35M | $41.70M | $38.62M | $38.10M | $35.53M | $44.04M | $45.43M |
| **Total Non-Current Liabilities** | $263.8M | $271.0M | $275.2M | $288.6M | $344.4M | $344.5M | $344.0M | $367.5M |
| **Total Liabilities** | $286.2M | $306.4M | $316.9M | $327.2M | $382.5M | $380.0M | $388.0M | $413.0M |
| **Total Debt (incl. Leases)** | $12.57M | $13.10M | $14K | $14K | $14.61M | $15.10M | $15.57M | $16.04M |
| Common Stock | $30K | $30K | $29K | $28K | $28K | $28K | $30K | $30K |
| Retained Earnings | -$637.7M | -$641.6M | -$825.4M | -$772.6M | -$822.2M | -$837.3M | -$798.7M | -$759.3M |
| Accumulated Other Comp. Income | -$181K | -$151K | -$146K | -$24K | $47K | -$6.0K | $161K | $305K |
| **Total Stockholders' Equity** | $20.82M | $10.59M | $12.75M | $37.21M | -$29.42M | -$44.73M | $34.02M | $70.87M |
| Total Equity | $20.82M | $10.59M | $12.75M | $37.21M | -$29.42M | -$44.73M | $34.02M | $70.87M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.23M | -$145.2M | -$163.6M | -$128.7M | -$57.80M | -$19.93M | -$97.34M | -$61.66M | -$30.07M | -$4.26M |
| Depreciation & Amortization | $559K | $606K | $652K | $675K | $619K | $559K | $514K | $315K | $183K | $233K |
| Stock-Based Compensation | $36.07M | $34.05M | $33.20M | $27.36M | $15.35M | -- | -- | -- | $4.38M | $1.16M |
| **Operating Cash Flow** | $19.70M | -$135.3M | -$120.8M | -$73.59M | -$45.92M | -$14.16M | -$69.52M | -$48.51M | -$19.44M | -$9.03M |
| Capital Expenditure | -$87K | -$358K | -$807K | -$358K | -$1.37M | -$569K | -$805K | -$1.06M | -$290K | -$50K |
| **Free Cash Flow** | $19.61M | -$135.7M | -$121.6M | -$73.95M | -$47.29M | -$14.73M | -$70.32M | -$49.57M | -$19.73M | -$9.08M |
| Purchases of Investments | -$196.4M | -$380.4M | -$303.9M | -$802.5M | -$118.7M | -$194.9M | -$251.8M | -$347.5M | -$290.9M | $0 |
| **Investing Cash Flow** | $228.0M | $95.40M | $144.8M | -$394.8M | $38.84M | $94.47M | $131.4M | -$142.5M | -$243.1M | -$50K |
| Common Stock Issued | $14.26M | $6.47M | $2.47M | $11.83M | $2.55M | $496K | $3.01M | $227.5M | $292.5M | $0 |
| Share Repurchases | -$68.63M | -$456K | -$50.00M | $0 | $0 | -- | -- | $0 | $0 | -$1.0K |
| **Financing Cash Flow** | -$132.6M | $127.1M | -$59.30M | $44.02M | $252.3M | -$879K | -$4.49M | $223.4M | $292.5M | $8.63M |
| **Net Change in Cash** | $115.1M | $87.11M | -$35.34M | -$424.4M | $245.2M | $79.44M | $57.42M | $32.41M | $29.96M | -$452K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $3.88M | -$52.88M | $49.61M | $15.11M | -$38.63M | -$39.33M | -$21.78M | -$32.85M |
| Depreciation & Amortization | $5.0K | $130K | $131K | $4.0K | $142K | $146K | $145K | $144K |
| Stock-Based Compensation | $3.21M | $14.22M | $8.51M | $207K | $9.24M | $9.17M | $8.18M | $8.19M |
| **Operating Cash Flow** | -$9.54M | -$25.92M | $98.00M | -$27.36M | -$40.24M | -$10.70M | -$66.67M | -$10.09M |
| Capital Expenditure | -- | -$17K | -$1.0K | -$12K | -$39K | -$35K | -$263K | -$35K |
| **Free Cash Flow** | -- | -$25.94M | $98.00M | -$27.37M | -$40.28M | -$10.73M | -$66.94M | -$10.12M |
| Purchases of Investments | -$9.91M | $0 | $0 | -$19.66M | -$54.21M | -$122.5M | -$120.9M | -$51.34M |
| **Investing Cash Flow** | $12.59M | $34.98M | $73.50M | $47.58M | $36.40M | $14.85M | -$29.40M | $58.62M |
| Common Stock Issued | $4.44M | $14.02M | $12.21M | $336K | $1.42M | $290K | $555K | $4.13M |
| Share Repurchases | $0 | $0 | -$3.38M | -$9.72M | -$51.10M | -$4.42M | -$456K | $0 |
| **Financing Cash Flow** | -$1.48M | $1.21M | -$43.13M | -$10.39M | -$50.50M | -$28.59M | $27.57M | $71.23M |
| **Net Change in Cash** | $1.57M | $10.27M | $128.4M | $9.83M | -$54.34M | -$24.44M | -$68.50M | $119.8M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 20.4% | -125.9% | -958.3% | -1119.4% | -89.9% | -31.8% | -1342.9% | -1334.4% | -287.8% | -18.1% |
| **Net Profit Margin** | -5.6% | -159.1% | -953.7% | -1251.3% | -91.5% | -26.6% | -1216.7% | -1233.1% | -300.7% | -25.5% |
| Return on Equity (ROE) | -35.6% | -204.9% | -185.7% | -49.1% | -16.2% | -5.0% | -24.0% | -12.7% | -9.8% | -- |
| Return on Assets (ROA) | -3.6% | -30.0% | -36.2% | -21.1% | -9.0% | -4.8% | -22.4% | -12.1% | -9.1% | -6.8% |
| Current Ratio | 9.07x | 9.51x | 10.87x | 17.16x | 34.40x | 20.01x | 12.79x | 19.89x | 17.93x | 10.20x |
| Quick Ratio | 8.94x | 9.38x | 10.62x | 16.99x | 34.10x | 19.86x | 12.67x | 19.56x | 17.63x | 9.19x |
| Debt to Equity | 0.00x | 0.23x | 0.20x | 0.07x | 0.06x | 0.00x | 0.00x | -- | -- | -- |
| **Revenue Growth (YoY)** | +157.0% | +432.0% | +66.8% | -83.7% | -15.8% | +837.5% | +60.0% | -50.0% | -40.1% | -5.0% |
| 5Y Revenue / Share Growth | +197.0% | +987.8% | +214.5% | -27.7% | -63.6% | -60.1% | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | +18.4% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | 35.9% | 38.6% | 8.2% | -69.9% | -89.6% | -125.9% | -257.8% |
| **Net Profit Margin** | -- | -11.5% | -5.6% | -49.9% | -107.7% | -125.7% | -159.1% | -289.8% |
| Return on Equity (ROE) | -- | -210.1% | -35.6% | -- | -- | -413.3% | -204.9% | -196.4% |
| Return on Assets (ROA) | -- | -8.1% | -3.6% | -24.0% | -39.6% | -33.3% | -30.0% | -33.6% |
| Current Ratio | 8.40x | 7.58x | 9.07x | 8.68x | 8.22x | 8.25x | 9.51x | 10.23x |
| Quick Ratio | 8.18x | 7.49x | 8.94x | 8.52x | 8.08x | 8.13x | 9.38x | 10.08x |
| Debt to Equity | 0.60x | 0.00x | 0.00x | -- | -- | 0.46x | 0.23x | 0.20x |
| **Revenue Growth (YoY)** | -60.3% | -8.0% | +151.1% | +154.3% | +102.9% | +286.8% | +378.8% | +804.7% |
| Operating Income Growth (YoY) | -74.2% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -74.4% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -75.9% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
